Reaktionsgleichung
[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[C:5]([CH3:9])=[CH:4][C:3]=1[S:10](Cl)(=[O:12])=[O:11].[NH2:14][C:15]1[CH:16]=[C:17]([C:21]2[NH:25][N:24]=[N:23][N:22]=2)[CH:18]=[CH:19][CH:20]=1>>[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[C:5]([CH3:9])=[CH:4][C:3]=1[S:10]([NH:14][C:15]1[CH:20]=[CH:19][CH:18]=[C:17]([C:21]2[NH:25][N:24]=[N:23][N:22]=2)[CH:16]=1)(=[O:12])=[O:11]Komponenten
3
Versuchsvorschrift
The product was prepared according to General Procedure 1, described in Example 1, starting with 2,4-dichloro-5-methylbenzene sulfonyl chloride (14.3 mg, 0.055 mmol) and 5-(3-aminophenyl)tetrazole (8 mg, 0.05 mmol) yielding 4.7 mg (24%) of the title compound. MS (ESI+) calcd for C14H11Cl2N5O2S 383.001051, found 383.000871.
Aufarbeitung
- customThe product was prepared
Quellen und Nachweise
- ORD-Eintrag
- ord-13b2b43df69d4b1eacfd6f2aa3df9427
- Quelldatensatz
- uspto-grants-2016_01
- Patentnummer
- US09233946B2
Verknüpfte Notizen
Wird geladen…